• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于天然产物的 HIV-1 蛋白酶抑制剂的从头设计。

Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products.

机构信息

DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico.

出版信息

Biomolecules. 2021 Dec 1;11(12):1805. doi: 10.3390/biom11121805.

DOI:10.3390/biom11121805
PMID:34944448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698858/
Abstract

Acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV) continues to be a public health problem. In 2020, 680,000 people died from HIV-related causes, and 1.5 million people were infected. Antiretrovirals are a way to control HIV infection but not to cure AIDS. As such, effective treatment must be developed to control AIDS. Developing a drug is not an easy task, and there is an enormous amount of work and economic resources invested. For this reason, it is highly convenient to employ computer-aided drug design methods, which can help generate and identify novel molecules. Using the de novo design, novel molecules can be developed using fragments as building blocks. In this work, we develop a virtual focused compound library of HIV-1 viral protease inhibitors from natural product fragments. Natural products are characterized by a large diversity of functional groups, many sp atoms, and chiral centers. Pseudo-natural products are a combination of natural products fragments that keep the desired structural characteristics from different natural products. An interactive version of chemical space visualization of virtual compounds focused on HIV-1 viral protease inhibitors from natural product fragments is freely available in the supplementary material.

摘要

获得性免疫缺陷综合征(AIDS)是由人类免疫缺陷病毒(HIV)引起的,它仍然是一个公共卫生问题。2020 年,有 68 万人死于与 HIV 相关的原因,有 150 万人感染。抗逆转录病毒药物是控制 HIV 感染的一种方法,但不能治愈艾滋病。因此,必须开发有效的治疗方法来控制艾滋病。开发一种药物并非易事,需要投入大量的工作和经济资源。出于这个原因,采用计算机辅助药物设计方法非常方便,它可以帮助生成和识别新的分子。使用从头设计,可以使用片段作为构建块来开发新的分子。在这项工作中,我们从天然产物片段开发了一个 HIV-1 病毒蛋白酶抑制剂的虚拟聚焦化合物库。天然产物的特点是具有大量的功能基团、许多 sp 原子和手性中心。伪天然产物是将不同天然产物的所需结构特征组合在一起的天然产物片段。天然产物片段的 HIV-1 病毒蛋白酶抑制剂虚拟化合物的化学空间可视化的交互式版本可在补充材料中免费获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/60b333487dc9/biomolecules-11-01805-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/6f7fea0f0648/biomolecules-11-01805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/f727b28d7e31/biomolecules-11-01805-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/64d54abd4038/biomolecules-11-01805-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/70cb0a604bc1/biomolecules-11-01805-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/92fc011a98d4/biomolecules-11-01805-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/6df2b3d771ec/biomolecules-11-01805-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/67c77121188e/biomolecules-11-01805-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/dd4f370c5a72/biomolecules-11-01805-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/156e2f511756/biomolecules-11-01805-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/660b3f792bc8/biomolecules-11-01805-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/bfc6c337632e/biomolecules-11-01805-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/aa9fad575b39/biomolecules-11-01805-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/f336918b75ff/biomolecules-11-01805-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/a5fbf76cdda2/biomolecules-11-01805-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/60b333487dc9/biomolecules-11-01805-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/6f7fea0f0648/biomolecules-11-01805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/f727b28d7e31/biomolecules-11-01805-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/64d54abd4038/biomolecules-11-01805-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/70cb0a604bc1/biomolecules-11-01805-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/92fc011a98d4/biomolecules-11-01805-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/6df2b3d771ec/biomolecules-11-01805-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/67c77121188e/biomolecules-11-01805-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/dd4f370c5a72/biomolecules-11-01805-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/156e2f511756/biomolecules-11-01805-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/660b3f792bc8/biomolecules-11-01805-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/bfc6c337632e/biomolecules-11-01805-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/aa9fad575b39/biomolecules-11-01805-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/f336918b75ff/biomolecules-11-01805-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/a5fbf76cdda2/biomolecules-11-01805-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6af/8698858/60b333487dc9/biomolecules-11-01805-g015.jpg

相似文献

1
Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products.基于天然产物的 HIV-1 蛋白酶抑制剂的从头设计。
Biomolecules. 2021 Dec 1;11(12):1805. doi: 10.3390/biom11121805.
2
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.用于治疗艾滋病毒/艾滋病的HIV-1蛋白酶抑制剂开发的最新进展
J Med Chem. 2016 Jun 9;59(11):5172-208. doi: 10.1021/acs.jmedchem.5b01697. Epub 2016 Jan 22.
3
Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.利用自然的智慧:从耐药性艾滋病毒治疗到阿尔茨海默病的天冬氨酰蛋白酶抑制剂设计
J Med Chem. 2009 Apr 23;52(8):2163-76. doi: 10.1021/jm900064c.
4
Inhibitors from natural products to HIV-1 reverse transcriptase, protease and integrase.天然产物抑制剂对 HIV-1 逆转录酶、蛋白酶和整合酶的抑制作用。
Mini Rev Med Chem. 2010 Dec;10(14):1331-44. doi: 10.2174/138955710793564133.
5
Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.HIV-1天冬氨酸蛋白酶非对称环状脲抑制剂的组合设计
Bioorg Med Chem. 2005 Sep 15;13(18):5492-501. doi: 10.1016/j.bmc.2005.06.026.
6
LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment.基于 LSTM 的药物设计,使用SELFIES 针对 HIV-1 蛋白酶抑制剂进行靶向从头生成,用于 AIDS 治疗。
PLoS One. 2024 Jun 21;19(6):e0303597. doi: 10.1371/journal.pone.0303597. eCollection 2024.
7
Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.通过铜(I)催化合成1,2,3-三唑及其进一步功能化实现对人类免疫缺陷病毒1型蛋白酶新型抑制剂的快速发现和构效关系分析。
J Med Chem. 2006 Dec 28;49(26):7697-710. doi: 10.1021/jm060754+.
8
Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.靶向蛋白质主链的HIV蛋白酶抑制剂设计:一种对抗耐药性的有效策略。
Acc Chem Res. 2008 Jan;41(1):78-86. doi: 10.1021/ar7001232. Epub 2007 Aug 28.
9
Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.设计并合成具有新型异山梨醇衍生 P2 配体的高效抗 HIV-1 蛋白酶抑制剂。
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2465-8. doi: 10.1016/j.bmcl.2014.04.008. Epub 2014 Apr 13.
10
Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.综述:人类免疫缺陷病毒的耐药性及天然产物对其的克服
In Vivo. 2009 Jan-Feb;23(1):1-6.

引用本文的文献

1
Artificial intelligence in assisting pathogenic microorganism diagnosis and treatment: a review of infectious skin diseases.人工智能辅助病原微生物诊断与治疗:感染性皮肤病综述
Front Microbiol. 2024 Oct 8;15:1467113. doi: 10.3389/fmicb.2024.1467113. eCollection 2024.
2
QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro.QuickFit:一种高通量基于 RT-qPCR 的检测方法,用于定量体外病毒生长和适应性。
Viruses. 2024 Aug 19;16(8):1320. doi: 10.3390/v16081320.
3
In Silico Drug Design and Discovery: Big Data for Small Molecule Design.

本文引用的文献

1
A guide to machine learning for biologists.生物学机器学习指南。
Nat Rev Mol Cell Biol. 2022 Jan;23(1):40-55. doi: 10.1038/s41580-021-00407-0. Epub 2021 Sep 13.
2
Advances in the Exploration of the Epigenetic Relevant Chemical Space.表观遗传相关化学空间的探索进展
ACS Omega. 2021 Aug 23;6(35):22478-22486. doi: 10.1021/acsomega.1c03389. eCollection 2021 Sep 7.
3
De novo molecular design and generative models.从头分子设计与生成模型。
计算机辅助药物设计与发现:小分子设计的大数据
Biomolecules. 2022 Dec 26;13(1):44. doi: 10.3390/biom13010044.
4
Progress and Impact of Latin American Natural Product Databases.拉丁美洲天然产物数据库的进展与影响。
Biomolecules. 2022 Aug 30;12(9):1202. doi: 10.3390/biom12091202.
5
Chemical Multiverse: An Expanded View of Chemical Space.化学多元宇宙:化学空间的扩展视角。
Mol Inform. 2022 Nov;41(11):e2200116. doi: 10.1002/minf.202200116. Epub 2022 Aug 23.
Drug Discov Today. 2021 Nov;26(11):2707-2715. doi: 10.1016/j.drudis.2021.05.019. Epub 2021 Jun 1.
4
Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.新型白桦脂酸衍生物的设计、合成及构效关系分析作为有效的 HIV 抑制剂。
Eur J Med Chem. 2021 Apr 5;215:113287. doi: 10.1016/j.ejmech.2021.113287. Epub 2021 Feb 14.
5
design of new chemical entities for SARS-CoV-2 using artificial intelligence.使用人工智能设计针对 SARS-CoV-2 的新化学实体。
Future Med Chem. 2021 Mar;13(6):575-585. doi: 10.4155/fmc-2020-0262. Epub 2021 Feb 16.
6
Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.从头药物设计的进展:从传统方法到机器学习方法。
Int J Mol Sci. 2021 Feb 7;22(4):1676. doi: 10.3390/ijms22041676.
7
Natural products in drug discovery: advances and opportunities.天然产物在药物发现中的应用:进展与机遇。
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28.
8
Visualization of very large high-dimensional data sets as minimum spanning trees.将超大型高维数据集可视化为最小生成树。
J Cheminform. 2020 Feb 12;12(1):12. doi: 10.1186/s13321-020-0416-x.
9
Review on natural products databases: where to find data in 2020.天然产物数据库综述:2020年何处获取数据
J Cheminform. 2020 Apr 3;12(1):20. doi: 10.1186/s13321-020-00424-9.
10
Chemoinformatics-based enumeration of chemical libraries: a tutorial.基于化学信息学的化学库枚举:教程
J Cheminform. 2020 Oct 27;12(1):64. doi: 10.1186/s13321-020-00466-z.